|
|
|
41
|
A3911
|
SERETIDE DISKUS 250MCG|50MCG INHR (GSK)
|
FLUTICASONE|SALMETEROL
|
SERETIDE DISKUS
|
60 DOSES
|
A
|
58.8
|
58.7973
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
A3911
|
SERETIDE DISKUS 250MCG|50MCG INHR (GSK) FLUTICASONE|SALMETER
|
FLUTICASONE|SALMETEROL
|
SERETIDE DISKUS
|
60 DOSES
|
A
|
61.43
|
61.43
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3912
|
SEROFLO CIPHALER 250MCG | 50M INHR (CIP/AHI) FLUTICASONE | SALMETEROL
|
FLUTICASONE|SALMETEROL
|
SEROFLO CIPHALER
|
60 DOSES
|
A
|
44.25
|
44.25
|
INHALER
|
1
|
INHR
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
A3926
|
RELVAR ELLIPTA 100MCG | 25MCG INHR (GSK/COL) FL
|
FLUTICASONE|VILANTEROL
|
RELVAR ELLIPTA
|
30 DOSES
|
A
|
41.67
|
41.67
|
INHALER
|
1
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A3926
|
RELVAR ELLIPTA 100MCG|25MCG INHR (GSK) F
|
FLUTICASONE|VILANTEROL
|
RELVAR ELLIPTA
|
30 DOSES
|
A
|
43.33
|
43.3301
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
A3926
|
RELVAR ELLIPTA 100MCG|25MCG INHR (GSK) F
|
FLUTICASONE|VILANTEROL
|
RELVAR ELLIPTA
|
30 DOSES
|
A
|
45.48
|
45.48
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3931
|
SERETIDE MDI 125/25 INHR (GSK/COL) FLUTICASON
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
C
|
56.57
|
56.57
|
INHALER
|
0
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A3931
|
SERETIDE MDI 125MCG|25MCG INHR (GSK) FLUTICASONE|SALMETEROL (C)
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
C
|
62.22
|
62.2224
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
A3931
|
SERETIDE MDI 125MCG|25MCG INHR (GSK) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
C
|
65.32
|
65.32
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3933
|
FLUTICASONE | SALMETEROL 125MCG | 25MCG INHR (CIP/AHI)
|
FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
120 DOSES
|
A
|
27.65
|
27.65
|
INHALER
|
1
|
INHR
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A3933
|
FLUTICASONE|SALMETEROL 125MCG|25MCG INHR (CIP)
|
FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
120 DOSES
|
A
|
27.65
|
27.6454
|
INHR
|
1
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3937
|
COMBIWAVE 125/25 INHR (GLP/ALI) FLUTICASONE/S
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
120 DOSES
|
C
|
27.18
|
27.18
|
INHALER
|
0
|
INHR
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ALI
|
ALL HEALTH INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2022-03-22
|
Delete from contract
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
2022-03-22
|
|
|
|
40
|
A3939
|
AROFLO 125MCG | 25MCG INHR (ARP/AHI) FLUTICASON
|
FLUTICASONE|SALMETEROL
|
AROFLO
|
120 DOSES
|
A
|
21.67
|
21.67
|
INHALER
|
1
|
INHR
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2022-06-30
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
2022-03-29
|
|
|
|
40
|
A393D
|
COMBIWAVE 125MCG | 25M INHR (GLP/ATB) FLUTICASONE | SALMETEROL
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
120 DOSES
|
C
|
27.18
|
27.18
|
INHALER
|
0
|
INHR
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
2022-03-22
|
|
|
|
42
|
A393E
|
COMBIWAVE 125MCG|25MCG INHR (GLP) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
150 DOSES
|
A
|
9.51
|
9.51
|
INHR
|
1
|
BOX
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
A393J
|
COMBIWAVE 125MCG|25MCG INHR (GLP) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
150 DOSES
|
A
|
9.51
|
9.51
|
INHR
|
1
|
CNN
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
CWS
|
CAPSULE WHOLESALE
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3941
|
SERETIDE MDI 50/25 INHR (GSK/COL) FLUTICASONE
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
C
|
48.20
|
48.20
|
INHALER
|
0
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A3941
|
SERETIDE MDI 50/25 INH (GSK) FLUTICASONE
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
A
|
53.01
|
53.0073
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
A3941
|
SERETIDE MDI 50MCG|25MCG INHR (GSK) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
A
|
55.67
|
55.67
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3942
|
FLUTICASONE | SALMETEROL 50MCG | 25MCG INHR (CIP/AHI)
|
FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
120 DOSES
|
A
|
27.10
|
27.10
|
INHALER
|
1
|
INHR
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|